Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECHO.L Regulatory News (ECHO)

  • There is currently no data for ECHO

Conversion of convertible loan notes

27 May 2016 14:56

RNS Number : 5794Z
Independent Resources PLC
27 May 2016
 

FOR IMMEDIATE RELEASE

 

27 May 2016

 

Independent Resources plc

("IRG" or the "Company") 

Conversion of convertible loan notes

IRG announces that today it exercised its option to repay through the issue of new ordinary shares of 0.01p each in the Company ("Shares"), the outstanding principal of £200,000 and accrued interest of £17,143 due on its issue of convertible loan notes ("CUL's"), announced to the market on 17 May 2016.

Pursuant to the terms of the CUL's, 452,380,952 Shares ("Repayment Shares") have been issued at a price of 0.048p per Share ("Conversion Price"), being the average of the three lowest closing mid-market prices of the Company's Shares between the issue date of the CUL's and the Company notifying the holders of the CUL's of IRG's intention to repay the CUL's in Shares, less a price discount of 10 per cent.

The Directors consider that it is in the best interests of the Company and its shareholders to repay the CULs with immediate effect through the issue of new equity thereby avoiding further material interest payments accruing and retaining cash within the Company.

Further, as announced to the market on 23 May 2016, a trade creditor has agreed to accept payment of indebtedness of £36,000 through the issue of Shares at the Conversion Price. Pursuant to this agreement the Company will issue 75,000,000 Shares to this creditor ("Creditor Shares").

Following the issue of the Repayment Shares and Creditor Shares referred to above and the 69,428,571 Shares expected to be admitted to trading on 1 June 2016 pursuant to the arrangements announced on 25 May 2016, there will be 1,262,504,294 ordinary shares of 0.01p each in the Company in issue. The figure of 1,262,504,294 Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the Disclosure and Transparency Rules.

The Repayment Shares and the Creditor Shares will rank pari passu with the Company's existing ordinary shares of 0.01p each. Application will be made for the Repayment Shares and the Creditor Shares to be admitted to trading on AIM ("Admission").

It is expected that Admission will become effective and dealings in the Repayment Shares and the Creditor Shares will commence at 8.00 a.m. on 3 June 2016.

CEO comment

Commenting on the repayment of the CUL's and their conversion into equity Greg Coleman, CEO of Independent Resources said:

"The Company remains committed to conserving its cash and improving its liquidity and both these objectives are served by our decision to repay the outstanding principal and accrued interest on the Company's convertible loan notes through the issue of equity."

For more information, please visit www.ir-plc.com or contact:

Greg Coleman

Independent Resources plc

020 3367 1134

Adam James

Panmure Gordon (UK) Limited

020 7886 2500

(Nominated Adviser & Joint Broker)

Oliver Stansfield

Brandon Hill Capital

020 3463 5000

Jonathan Evans

(Joint Broker)

Simon Hudson

Tavistock Communications

020 7920 3150

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRBXGDUXUDBGLR
Date   Source Headline
25th Jul 20227:00 amRNSOperational Update re Enhancement Plan
7th Jul 20227:00 amRNSH1 2022 Production and Operational Update
30th Jun 20227:00 amRNSChange of Adviser
27th Jun 20221:13 pmRNSResult of Annual General Meeting
27th Jun 20227:00 amRNSExtension to publication of 2021 Accounts
17th Jun 20229:40 amRNSHolding(s) in Company
9th Jun 20224:41 pmRNSDirectorate Change
1st Jun 20225:08 pmRNSNotice of Annual General Meeting
30th May 20227:00 amRNSArgentina Operational Update
3rd May 20227:00 amRNSArgentina Commercial Update
11th Apr 20225:34 pmRNSBlock Admission and Block Admission Interim Review
5th Apr 20227:00 amRNSProduction Update
31st Jan 202212:00 pmRNSTotal Voting Rights
14th Jan 20221:25 pmRNSDirectorate Changes
14th Jan 202212:36 pmRNSProduction Update, Acquisition and Issue of Equity
9th Dec 20217:00 amRNSOperational Update
29th Oct 20214:30 pmRNSTotal Voting Rights
14th Oct 20217:00 amRNSWell Intervention Programme
12th Oct 20211:16 pmRNSBlock Admission Update
5th Oct 20217:00 amRNSOperational Update
1st Oct 20217:00 amRNSSuccessful Loan Restructuring
30th Sep 20217:00 amRNSInterim Results
7th Sep 20216:09 pmRNSResult of General Meeting
26th Aug 20217:00 amRNSOperational Update
16th Aug 20215:19 pmRNSNotice of General Meeting
28th Jul 20214:41 pmRNSSecond Price Monitoring Extn
28th Jul 20214:35 pmRNSPrice Monitoring Extension
28th Jul 202111:05 amRNSSecond Price Monitoring Extn
28th Jul 202111:00 amRNSPrice Monitoring Extension
21st Jun 20217:00 amRNSOperational Update - Q2 Update 2021
16th Jun 20211:00 pmRNSResult of AGM
10th Jun 20218:33 amRNSFurther re Issue of Warrants
1st Jun 20217:00 amRNSArgentina: VAT Update
19th May 20217:00 amRNSDirector/PDMR Shareholding
17th May 20214:48 pmRNSPublication of Annual Report and Notice of AGM
12th May 20212:06 pmRNSSecond Price Monitoring Extn
12th May 20212:00 pmRNSPrice Monitoring Extension
12th May 202111:06 amRNSSecond Price Monitoring Extn
12th May 202111:00 amRNSPrice Monitoring Extension
6th May 20217:00 amRNSFinal Results
30th Apr 20213:00 pmRNSTotal Voting Rights
19th Apr 20217:00 amRNSOperational and Commercial Update - Q1 2021
13th Apr 20215:43 pmRNSExercise of Warrants and Total Voting Rights
13th Apr 20212:05 pmRNSSecond Price Monitoring Extn
13th Apr 20212:00 pmRNSPrice Monitoring Extension
12th Apr 20212:00 pmRNSPrice Monitoring Extension
12th Apr 202111:45 amRNSExercise of Warrants and Total Voting Rights
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:36 pmRNSPrice Monitoring Extension
30th Mar 20212:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.